Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The National Comprehensive Cancer Network (NCCN) is a not-for-profit alliance of 33 leading cancer centers devoted to patient care, research, and education. NCCN is globally recognized for developing the NCCN Clinical Practice Guidelines in Oncology, which serve as the standard for clinical policy in cancer management and are the most frequently updated guidelines in medicine. These guidelines help clinicians make informed decisions about treatment, ensuring patients receive the most effective care based on the latest evidence. Beyond guidelines, NCCN facilitates clinical research through its Oncology Research Program and provides extensive continuing medical education for healthcare professionals. The organization also focuses on patient advocacy and international collaborations to improve the quality and efficiency of cancer care worldwide. Member institutions include prestigious centers such as Memorial Sloan Kettering, MD Anderson, and Dana-Farber, which collaborate to define the best standards of care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NCCN-designated cancer center.